| http://www.w3.org/ns/prov#value | - Number of Participants With Treatment Related Adverse Events of Somatropin: <15 Years of Age vs. >=15 Years of Age. [ Time Frame: Up to 3 years ] [ Designated as safety issue: Yes ]To determine whether age is a significant risk factor in the frequency of treatment related adverse events.
|
